Physician profile
Mackenzie Malek
NPI 1023467693
$6,808.79
in general payments reported to CMS, 2019-2025
19 companies · $754 in 2025
The $754 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2021: $36.82 · 2023: $5,236 · 2024: $426 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,613 · Travel and Lodging: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,613.48 |
| Travel and Lodging | $302.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,460.36 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $355.52 | 2019 | |
| Sumitomo Pharma America, INC. | $185.57 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $176.61 | 2024-2025 | |
| Hologic Sales and Service, LLC | $110.90 | 2021-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $96.88 | 2023 | Myrisk |
| Sage Therapeutics, LLC | $79.02 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $59.45 | 2023-2024 | |
| Organon LLC | $39.20 | 2024-2025 | Jada System |
| Exact Sciences Corporation | $35.91 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $34.57 | 2025 | |
| Millicent US INC | $34.29 | 2023-2025 | Intrarosa, Femlyv |
| Lilly USA, LLC | $32.21 | 2024 | Zepbound, Jardiance |
| Shield Therapeutics INC | $22.41 | 2024 | |
| Astellas Pharma US INC | $19.76 | 2024 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $18.50 | 2025 | |
| Coopersurgical, INC. | $18.12 | 2023 | Paragard T 380a |
| Abbvie INC. | $14.80 | 2023 | |
| Supernus Pharmaceuticals, INC. | $14.71 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Malek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.